Show Stocks and Investing Publications • Fri, September 9, 2022
Gary Nachman Maintained (ALNY) at Hold with Increased Target to $200 on, Sep 9th, 2022
an-maintained-alny-at-hold-with-increased-target-to-200-on-sep-9th-2022.html
Stocks and Investing on Sun, Oct 27th, 2024Gary Nachman of BMO Capital, Maintained "Alnylam Pharmaceuticals, Inc." (ALNY) at Hold with Increased Target from $192 to $200 on, Sep 9th, 2022.
Gary has made no other calls on ALNY in the last 4 months.
There are 7 other peers that have a rating on ALNY. Out of the 7 peers that are also analyzing ALNY, 4 agree with Gary's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- David Lebowitz of "Morgan Stanley" Maintained at Hold with Decreased Target to $164 on, Friday, July 15th, 2022
- Olivia Brayer of "Cantor Fitzgerald" Initiated at Hold and Held Target at $175 on, Wednesday, July 13th, 2022
- Debjit Chattopadhyay of "Guggenheim" Downgraded from Strong Buy to Hold on, Monday, June 27th, 2022
- Mani Foroohar of "SVB Leerink" Maintained at Hold with Increased Target to $98 on, Wednesday, June 15th, 2022
These are the ratings of the 3 analyists that currently disagree with Gary
- Joseph Stringer of "Needham" Maintained at Strong Buy with Increased Target to $240 on, Thursday, August 4th, 2022
- Keay Nakae of "Chardan Capital" Maintained at Strong Buy with Increased Target to $250 on, Thursday, August 4th, 2022
- Myles Minter of "William Blair" Initiated at Buy on, Tuesday, June 7th, 2022